Elixir Capital Intrinsic Value
Elixir Capital (ELIXIR) median intrinsic value is ₹106.67 from 9 valuation models (range ₹49–₹188), vs current price ₹122.45 — -12.9% downside (Trading Above Median Value), margin of safety -14.8%. Browse ELIXIR financial statements for revenue, profit, balance sheet and cash flow data.
ELIXIR Valuation Methods Summary — DCF, Graham Number & P/E
Elixir Capital intrinsic value across 9 models vs current price ₹122.45 — upside/downside and value range per method. For current market price and key ratios, visit Elixir Capital share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹141.12 | ₹112.90 - ₹169.34 | +15.2% | EPS: ₹11.76, Sector P/E: 12x |
| Book Value Method | asset | ₹106.67 | ₹96.00 - ₹117.34 | -12.9% | Book Value/Share: ₹133.33, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹73.33 | ₹66.00 - ₹80.66 | -40.1% | Revenue/Share: ₹73.33, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹133.33 | ₹120.00 - ₹146.66 | +8.9% | EBITDA: ₹16.00Cr, EV/EBITDA: 5x |
| Simple DCF (5Y) | dcf | ₹48.98 | ₹39.18 - ₹58.78 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹75.26 | ₹67.73 - ₹82.79 | -38.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹96.90 | ₹87.21 - ₹106.59 | -20.9% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹133.33 | ₹120.00 - ₹146.66 | +8.9% | ROE: 10.0%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹187.83 | ₹169.05 - ₹206.61 | +53.4% | EPS: ₹11.76, BVPS: ₹133.33 |
ELIXIR Intrinsic Value vs Market Price — All Valuation Models
Elixir Capital fair value range ₹49–₹188 vs current market price ₹122.45 across 9 valuation models. Also explore Elixir Capital share price performance to track price trends across different timeframes.
ELIXIR Intrinsic Value Analysis — Undervalued or Overvalued?
Elixir Capital median intrinsic value ₹106.67, current price ₹122.45 — Trading Above Median Value by 12.9%, margin of safety -14.8%.
What is the intrinsic value of ELIXIR?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Elixir Capital (ELIXIR) is ₹106.67 (median value). With the current market price of ₹122.45, this represents a -12.9% variance from our estimated fair value.
The valuation range spans from ₹48.98 to ₹187.83, indicating ₹48.98 - ₹187.83.
Is ELIXIR undervalued or overvalued?
Based on our multi-method analysis, Elixir Capital (ELIXIR) appears to be trading above median value by approximately 12.9%.
ELIXIR Financial Health — Key Ratios vs Industry Benchmarks
Elixir Capital financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 10.0% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 39.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.38x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ELIXIR Cash Flow Quality — Operating & Free Cash Flow
Elixir Capital operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-17 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹5 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-2 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |